statistiche ricercatore

PERLETTI, GIANPAOLO

Distribuzione geografica

Continente	#
NA - Nord America	10.527
EU - Europa	7.069
AS - Asia	1.452
OC - Oceania	29
SA - Sud America	20
AF - Africa	18
Continente sconosciuto - Info sul continente non disponibili	13
Totale	19.128

Salva come PNG Salva come JPEG

Nazione	#
US - Stati Uniti d'America	10.485
IT - Italia	3.859
UA - Ucraina	1.239
SE - Svezia	644
TR - Turchia	590
VN - Vietnam	407
IE - Irlanda	368
FI - Finlandia	296
CN - Cina	295
DE - Germania	235
GB - Regno Unito	216
FR - Francia	80
IN - India	57
CA - Canada	41
BE - Belgio	39
AU - Australia	22
IQ - Iraq	14
BG - Bulgaria	13
BR - Brasile	13
EU - Europa	13
IR - Iran	11
PK - Pakistan	10
PL - Polonia	10
HK - Hong Kong	9
NL - Olanda	8
ES - Italia	7
NZ - Nuova Zelanda	7
RU - Federazione Russa	7
SK - Slovacchia (Repubblica Slovacca)	7
TW - Taiwan	7
KR - Corea	6
MY - Malesia	6
DK - Danimarca	5
ID - Indonesia	5
IL - Israele	5
NP - Nepal	5
RO - Romania	5
AR - Argentina	4
CH - Svizzera	4
EG - Egitto	4
GR - Grecia	4
NG - Nigeria	4
PH - Filippine	4
PT - Portogallo	4
ZA - Sudafrica	4
AT - Austria	3
HU - Ungheria	3
JP - Giappone	3
LU - Lussemburgo	3
SD - Sudan	3
SG - Singapore	3
BH - Bahrain	2
JO - Giordania	2
LI - Liechtenstein	2
MD - Moldavia	2
MM - Myanmar	2
RS - Serbia	2
SA - Arabia Saudita	2
TH - Thailandia	2
AE - Emirati Arabi Uniti	1
AF - Afghanistan, Repubblica islamica di	1
AL - Albania	1
CL - Cile	1
CO - Colombia	1
CY - Cipro	1
CZ - Repubblica Ceca	1
DZ - Algeria	1
EC - Ecuador	1
EE - Estonia	1
ET - Etiopia	1
KE - Kenya	1
KZ - Kazakistan	1
MK - Macedonia	1
PA - Panama	1
YE - Yemen	1
Totale	19.128

Salva come PNG Salva come JPEG

Città	#
Milan	2.787
Fairfield	1.592
Woodbridge	1.031
Jacksonville	951
Chandler	821
Houston	785
Ashburn	768
Seattle	670
Wilmington	611
Cambridge	566
Ann Arbor	491
Princeton	368
Dublin	364
Dearborn	343
Nyköping	337
Izmir	295
Rome	212
Dong Ket	195
Como	167
San Mateo	122
San Diego	115
Beijing	76
Ogden	76
New York	43
Nanjing	35
Kocaeli	33
London	33
Hefei	32
Kunming	31
Verona	30
Los Angeles	26
Washington	26
Pioltello	24
Boardman	22
Toronto	22
Rozzano	21
Brussels	20
Norwalk	17
Auburn Hills	14
Guangzhou	14
Helsinki	14
Pune	14
Sofia	13
Chicago	11
Nanchang	11
Redmond	11
Düsseldorf	10
Glasgow	10
Kilburn	9
Ponte Lambro	9
Shenyang	9
Bengaluru	8
Ottawa	8
Phoenix	8
Berlin	7
Chiswick	7
Edinburgh	7
Fuzhou	7
Jinan	7
New Bedfont	7
Stockholm	7
Varese	7
Warsaw	6
Zhengzhou	6
Brisbane	5
Duhok	5
Falls Church	5
Hanoi	5
Hong Kong	5
Islington	5
Jerusalem	5
Magnago	5
Melbourne	5
New Orleans	5
San Francisco	5
Taizhou	5
Amsterdam	4
Buenos Aires	4
Chengdu	4
Cleveland	4
Dallas	4
Hangzhou	4
Hebei	4
Hyderabad	4
Kaohsiung City	4
Kolkata	4
Kuala Lumpur	4
Lahore	4
Ningbo	4
Sydney	4
Ardabil	3
Arlington	3
Cairo	3
Carson City	3
Cernusco sul Naviglio	3
Changsha	3
Copenhagen	3
Cremona	3
Florence	3
Franca	3
Totale	14.545

Salva come PNG Salva come JPEG

Nome	#
Infectious complications of endourological treatment of kidney stones: A meta-analysis of randomized clinical trials	204
Combined effect of polymorphisms in Rad51 and Xrcc3 on breast cancer risk and chromosomal radiosensitivity	182
The Integral Theory System Questionnaire: an anatomically directed questionnaire to determine pelvic floor dysfunctions in women	182
5-Lipoxygenase and anandamide hydrolase (FAAH) mediate the antitumor activity of cannabidiol, a non-psychoactive cannabinoid.	180
Role in anxiety behavior of the endocannabinoid system in the prefrontal cortex	175
Analysis of chromosomal radiosensitivity of healthy BRCA2 mutation carriers and non-carriers in BRCA families with the G2 micronucleus assay	174
Eradication of Chlamydia trachomatis parallels symptom regression in chronic bacterial prostatitis patients treated with a fluoroquinolone-macrolide combination.	173
Polymorphisms in nonhomologous end-joining genes associated with breast cancer risk and chromosomal radiosensitivity.	164
National Institutes of Health Chronic Prostatitis Symptom Index (NIH-CPSI) symptom evaluation in multinational cohorts of patients with chronic prostatitis/chronic pelvic pain syndrome.	164
Aminoglycoside antibiotics for NIH category II chronic bacterial prostatitis: A single-cohort study with one-year follow-up	163
Chronic bacterial prostatitis: enterococcal disease?	161
ANALYSIS OF CALCIUM-DEPENDENT PROTEIN-KINASE-C ISOFORMS IN THE EARLY STAGES OF DIETHYLNITROSAMINE-INDUCED RAT HEPATOCARCINOGENESIS	159
Increased chromosomal radiosensitivity in asymptomatic carriers of a heterozygous BRCA1 mutation	159
Discrepancies between in silico and in vitro data in the functional analysis of a breast cancer-associated polymorphism in the XRCC6/Ku70 gene.	158
Effect of HIF-1 modulation on the response of two- and three-dimensional cultures of human colon cancer cells to 5-fluorouracil	158
Azithromycin: mechanisms of action and their relevance for clinical applications.	156
Multimodal therapy for category III chronic prostatitis/chronic pelvic pain syndrome in UPOINTS phenotyped patients	156
Computer-assisted quantitative assessment of prostatic calcifications in patients with chronic prostatitis	156
Are oxygen radicals responsible for the acute cardiotoxicity of doxorubicin?	155
α-blockers and antibiotics, alone or in combination, improve symptoms in men with chronic prostatitis/chronic pelvic pain syndrome.	153
Prevalence of erectile and ejaculatory dysfunction in men with chronic prostatitis/chronic pelvic pain syndrome	153
Macrolides for the treatment of chronic bacterial prostatitis: an effective application of their unique pharmacokinetic and pharmacodynamic profile (Review).	152
Fluoroquinolone-macrolide combination therapy for chronic bacterial prostatitis: retrospective analysis of pathogen eradication rates, inflammatory findings and sexual dysfunction.	152
Use of the UPOINT chronic prostatitis/chronic pelvic pain syndrome classification in European patient cohorts: sexual function domain improves correlations.	151
National institute of health chronic prostatitis symptom index (CPSI) symptom evaluation in patients with chronic prostatitis / chronic pelvic pain syndrome - A multinational study in 1,563 patients	149
Characterization of the c.190T>C missense mutation in BRCA1 codon 64 (Cys64Arg).	148
Comparative analysis of molecular strategies attenuating positional effects in lentiviral vectors carrying multiple genes	146
Semen analysis in chronic bacterial prostatitis: diagnostic and therapeutic implications.	146
Structure and function of the extraembryonic membrane persisting around the larvae of the parasitoid Toxoneuron nigriceps.	144
A new approach to the direct detection of free radicals in the intact myocardium.	143
Efficacy and safety of second-line agents for treatment of metastatic castration-resistant prostate cancer progressing after docetaxel. A systematic review and meta-analysis	143
Finafloxacin for the treatment of urinary tract infections	142
Reply to: Clarification to provide further understanding of the conduct and design of TROPIC: A Phase 3 trial of cabazitaxel versus mitoxantrone in patients with metastatic castration-resistant prostate cancer	142
Anti-infective treatment of bacterial urinary tract infections.	141
PROTECTIVE EFFECTS OF SPIN-TRAPPING AGENTS ON ADRIAMYCIN-INDUCED CARDIOTOXICITY IN ISOLATED RAT ATRIA	140
Natural history of human papillomavirus infection in non-vaccinated young males: low clearance probability in high-risk genotypes	140
DIFFERENTIAL PHORBOL ESTER GROWTH MODULATION AND PROTEIN-KINASE-C ISOENZYME EXPRESSION IN RAT HEPATOMA-CELLS VS NON NEOPLASTIC RAT HEPATOCYTES	139
INTERACTION OF CU(II) AND CU(II)-ANTHRACYCLINE COMPLEXES WITH PROTEIN-KINASE-C - SPECTROMAGNETIC ASSESSMENT OF THE INHIBITORY EFFECT	138
Multiparametric magnetic resonance imaging characteristics of normal, benign and malignant conditions in the prostate	138
Antimicrobials in urogenital infections.	136
Risk factors analysis in patients with chronic prostatitis/chronic pelvic pain syndrome (CP/CPPS) from Finland, Germany, Italy and Switzerland: Results of a multinational observational study	135
THE INHIBITORY EFFECT OF CU(II) ON PROTEIN-KINASE-C IS ENHANCED BY ANTHRACYCLINES - AN ESR STUDY	133
A switch therapy protocol with intravenous azithromycin and ciprofloxacin combination for severe, relapsing chronic bacterial prostatitis: a prospective non-comparative pilot study.	133
PARTIAL-PURIFICATION OF PROTEIN-KINASE-C ISOENZYMES FROM RAT-LIVER	132
FRAIL scale as a predictor of complications and mortality in older patients undergoing reconstructive surgery for non-melanoma skin cancer	132
Phosphatidylethanolamine N-methyltransferase 2 and CTP-phosphocholine cytidylyltransferase expressions are related with protein kinase C isozymes in developmental liver growth	131
Prevention and modulation of aminoglycoside ototoxicity (Review)	131
Emerging drugs for bacterial urinary tract infections.	131
Efficacy of repeated cycles of combination therapy for the eradication of infecting organisms in chronic bacterial prostatitis	130
Polymorphisms in nonhomologous end joining genes associated with breast cancer risk and chromosomal radiosensitivity.	130
Re: Samplaski et al.: Inclusion of erectile domain to UPOINT phenotype does not improve correlation with symptom severity in men with chronic prostatitis/chronic pelvic pain syndrome. (Urology 2011;78:653-658).	130
Inflammatory cues acting on the adult intestinal stem cells and the early onset of cancer (Review)	129
Growth factors and chemokines: a comparative functional approach between invertebrates and vertebrates.	129
A severely symptomatic case of anaerobic chronic bacterial prostatitis successfully resolved with moxifloxacin therapy.	129
Topographic and quantitative relationship between prostate inflammation, proliferative inflammatory atrophy and low-grade prostate intraepithelial neoplasia: A biopsy study in chronic prostatitis patients	129
Chlamydia trachomatis infection is related to premature ejaculation in chronic prostatitis patients: Results from a cross-sectional study	129
PROTEIN-KINASE-C ISOZYMES DURING LIVER-REGENERATION	128
p21(Waf1/Cip1) and p53 are downstream effectors of protein kinase C delta in tumor suppression and differentiation in human colon cancer cells	126
A polymorphism in the promoter region of Ku70/XRCC6, associated with breast cancer risk and oestrogen exposure.	126
PROTEIN-KINASE-C ISOZYME PATTERN IN LIVER HYPERPLASIA	125
THE ACTIVITY OF A BETA-SUBTYPE OF PROTEIN-KINASE-C PURIFIED FROM NUCLEI OF HUMAN NEUTROPHILS IS ENHANCED BY TREATMENT WITH PHORBOL 12-MYRISTATE 13-ACETATE	125
Antimicrobial therapy for chronic bacterial prostatitis.	123
Herbal medicines for urinary stone treatment. A systematic review	123
The association between prostatitis and prostate cancer. Systematic review and meta-analysis	121
Emerging second-line therapies for advanced, androgen deprivation-refractory prostate cancer in the post-docetaxel setting	120
Comparative analysis of immune responses and cytokine profiles elicited in rabbits by the combined use of recombinant fowlpox viruses, plasmids and virus-like particles in prime-boost vaccination protocols against SHIV	119
A switch therapy protocol with intravenous azithromycin and ciprofloxacin combination for severe, relapsing chronic bacterial prostatitis: a prospective non-comparative pilot study.	119
Eradication of unusual pathogens by combination pharmacological therapy is paralleled by improvement of signs and symptoms of chronic prostatitis syndrome	118
Activity of Serenoa repens, lycopene and selenium on prostatic disease: evidences and hypotheses.	118
Reduction of PSA values by combination pharmacological therapy in patients with chronic prostatitis: implications for prostate cancer detection.	117
Distinctive cellular roles for novel protein kinase C isoenzymes	117
Resistance of uropathogens to antibacterial agents: Emerging threats, trends and treatments	117
Current knowledge of the potential links between inflammation and prostate cancer	117
Chlamydia trachomatis versus common uropathogens as a cause of chronic bacterial prostatitis: Is there any difference? Results of a prospective parallel-cohort study	116
Collagen organization in leech wound healing.	115
Leech responses to tissue transplantation	115
Hypoxia as a risk factor for doxorubicin-induced cardiotoxicity: a NMR evaluation.	114
Evaluation of patients with chronic prostatitis-chronic pelvic pain syndrome by clinical phenotyping in two specialized European institutions.	113
VEGF stimulates angiogenesis in Hirudo medicinalis.	112
Leeches: Immune response, angiogenesis and biomedical applications	112
Effect of doxorubicin on calcium receptors of myocardial cells.	111
Prostatic calcifications and symptoms of chronic prostatitis/chronic pelvic pain syndrome	111
Nutraceutical treatment and prevention of benign prostatic hyperplasia and prostate cancer	108
Wound repair in Hirudo medicinalis: phases and response modulation	107
How does the pre-massage and post-massage 2-glass test compare to the meares-stamey 4-glass test in men with chronic prostatitis/chronic pelvic pain syndrome?	107
Lentivirus-mediated RNA interference of Ku70 to enhance radiosensitivity of human mammary epithelial cells.	107
Efficacy of second line agents for the treatment of metastatic castration-resistant prostate cancer progressing after docetaxel: Systematic review and meta-analysis.	107
Green tea catechins for chemoprevention of prostate cancer in patients with histologically-proven HG-PIN or ASAP. Concise review and meta-analysis	106
ANALYSIS OF CALCIUM-DEPENDENT PROTEIN-KINASE-C ISOENZYMES IN INTRINSICALLY RESISTANT CLONED LINES OF LOVO CELLS - REVERSAL OF RESISTANCE BY KINASE INHIBITOR 1-(5-ISOQINOLINYLSULFONYL) 2-METHYLPIPERAZINE	105
Generation of VSV-G pseudotyped lentiviral particles in 293T cells	105
Collagen reorganization in leech wound healing.	105
The radiosensitizing effect of Ku70/80 knockdown in MCF10A cells irradiated with X-rays and p(66)+Be(40) neutrons.	105
Influence of infection on the distribution patterns of NIH-Chronic Prostatitis Symptom Index scores in patients with chronic prostatitis/chronic pelvic pain syndrome (CP/CPPS).	104
Resistance of human leukemic cell lines to 1-beta-D-arabinofuranosylcytosine: characterization of an experimental model	103
Inflammation, Prostatitis, Proliferative Inflammatory Atrophy: "fertile ground" for prostate cancer development?	103
Enhanced distribution of 4th-generation fluoroquinolones in the prostatic tissue.	102
Clinical phenotyping of patients with Chronic Prostatitis/Chronic Pelvic Pain Syndrome in two specialized European institutions.	102
Antimicrobials in urogenital infections.	102
Prevalence of sexual dysfunction in men with chronic prostatitis/chronic pelvic pain syndrome.	101
Hirudo medicinalis: un nuovo modello sperimentale per lo studio dell’angiogenesi	101
Totale	13.266

Salva come PNG Salva come JPEG

Categoria	#
all - tutte	63.500
article - articoli	0
book - libri	0
conference - conferenze	0
curatela - curatele	0
other - altro	0
patent - brevetti	0
selected - selezionate	0
volume - volumi	0
Totale	63.500

Salva come PNG Salva come JPEG

	Totale	Lug	Ago	Sett	Ott	Nov	Dic	Gen	Feb	Mar	Apr	Mag	Giu
2018/2019	1.155	0	0	0	0	0	0	0	0	0	0	485	670
2019/2020	3.844	182	140	167	712	286	447	554	476	287	285	71	237
2020/2021	2.806	54	249	87	267	149	344	83	223	398	223	268	461
2021/2022	1.970	190	191	128	173	31	99	82	152	258	240	154	272
2022/2023	2.265	262	122	235	199	170	488	3	284	285	79	75	63
2023/2024	4.586	675	731	765	812	905	256	60	109	148	118	7	0
Totale													19.341